Lung cancer remains the commonest global cause of death from cancer [1]. Notable advances in the diagnosis of cancers have been the use of immunochemistry in pathological diagnosis, the characterisation of the poorly differentiated malignant tumour, or in the identification of the origin of the tumour, whether primary or meta-static, and its emerging role in lung cancer prognosis and therapy. Furthermore, lung cancer management has evolved to a multidisciplinary level involving both pa-thologists and clinicians, some of whom may not under-stand the ever increasing contribution of immunochem-istry to diagnosis, improving targeted therapy and deter-mining prognosis. In this review, we do not discuss the basic principles of immunostaining prot...
Lung cancer is a disease that in recent years has become one of the greatest threats to modern socie...
The use of immunohistochemistry for the determination of pulmonary carcinoma biomarkers is a well-es...
Lung cancer is the cancer responsible for the most deaths worldwide. Treatment is multimodal and bas...
Lung cancer remains the commonest global cause of death from cancer [1]. Notable advances in the dia...
Non-small cell lung cancer is possibly the solid tumor with more potential drugable molecular target...
Immunohistochemistry is a widely available technique that is less challenging and can provide clinic...
To highlight the role of immunohistochemistry to lung cancer classification on the basis of existing...
Since the 2015 WHO classification was introduced into clinical practice, immunohistochemistry (IHC) ...
Lung cancer is the world's second leading cause of death, with an estimated 9.6 million deaths in 20...
The identification of certain genomic alterations (EGFR, ALK, ROS1, BRAF) or immunological markers (...
Lung cancer is the leading cause of cancer deaths throughout the world. The majority of patients are...
An in-depth understanding of lung cancer biology and mechanisms of tumor progression has facilitated...
Objectives: To assess immunohistochemical (IHC) stains differentially expressed between different ty...
Quantitative immunohistochemistry remains an important tool in translational lung cancer research wi...
istopathologic classification of lung carcinoma is important, as a prognostic factor and in the eval...
Lung cancer is a disease that in recent years has become one of the greatest threats to modern socie...
The use of immunohistochemistry for the determination of pulmonary carcinoma biomarkers is a well-es...
Lung cancer is the cancer responsible for the most deaths worldwide. Treatment is multimodal and bas...
Lung cancer remains the commonest global cause of death from cancer [1]. Notable advances in the dia...
Non-small cell lung cancer is possibly the solid tumor with more potential drugable molecular target...
Immunohistochemistry is a widely available technique that is less challenging and can provide clinic...
To highlight the role of immunohistochemistry to lung cancer classification on the basis of existing...
Since the 2015 WHO classification was introduced into clinical practice, immunohistochemistry (IHC) ...
Lung cancer is the world's second leading cause of death, with an estimated 9.6 million deaths in 20...
The identification of certain genomic alterations (EGFR, ALK, ROS1, BRAF) or immunological markers (...
Lung cancer is the leading cause of cancer deaths throughout the world. The majority of patients are...
An in-depth understanding of lung cancer biology and mechanisms of tumor progression has facilitated...
Objectives: To assess immunohistochemical (IHC) stains differentially expressed between different ty...
Quantitative immunohistochemistry remains an important tool in translational lung cancer research wi...
istopathologic classification of lung carcinoma is important, as a prognostic factor and in the eval...
Lung cancer is a disease that in recent years has become one of the greatest threats to modern socie...
The use of immunohistochemistry for the determination of pulmonary carcinoma biomarkers is a well-es...
Lung cancer is the cancer responsible for the most deaths worldwide. Treatment is multimodal and bas...